Multibiomarker Disease Activity Score May Be Objective Tool For Monitoring RA, Systematic Review Indicates

January 25, 2023

Rheumatology Advisor (1/24) reports, “The multibiomarker disease activity (MBDA) score may be an objective tool for monitoring rheumatoid arthritis (RA), according to” a systematic review and meta-analysis that included “a total of 24 and 8 studies...in t...